SLC2A1 and lung cancer: The aim of current study was to elucidate the regulatory mechanism between HPV16E6/E7, PTEN, TXNIP, HIF-1α, and GLUT1 in lung cancer cells and provide a new strategy for the treatment of HPV-related lung cancer.